Posted on January 25, 2016 by #LCSM Chat
At the recent State of the Union Address, President Obama struck a bipartisan chord by announcing a new “Cancer Moonshot” program with Vice President Joe Biden serving as “mission control” and leading a charge of renewed efforts to remove perceived barriers to scientific collaboration and achieve unprecedented progress to understand, prevent, and more effectively treat cancers of all types. Vice President Biden has a very personal stake, as his son Beau died of a glioblastoma (a primary brain cancer) in May, 2015. He has been meeting with several leading national cancer experts… Read More
Posted on January 11, 2016 by Gray Connections
Our topic for the next #LCSM Tweet Chat on Thursday, January 14th at 5 PM Pacific (8 PM Eastern) is “What Clinical Questions Can We Study to Improve Lung Cancer Treatment Outcomes?” In this chat, moderator Dr. David Tom Cooke (@DavidCookeMD) will facilitate brainstorming for clinical trial ideas. The chat is a continuation of #LCSM Chat’s ongoing Patient Centered Outcomes Research Institute (PCORI) funded project, entitled “Empowering Patients and Their Families to Improve Outcomes That Are Most Important to Them after Surgery and Other Therapies for Lung Cancer.” Patient-centered outcomes… Read More
Posted on December 14, 2015 by #LCSM Chat
Some years are bigger than others, and by just about any measure, 2015 was a banner year for the lung cancer community. We saw new drug approvals for a wide range of lung cancer patients, including immunotherapy for patients with both squamous and non-squamous advanced NSCLC, as well as very recent approvals as holiday presents for patients with an EGFR mutation or ALK rearrangement. We saw many important trials in lung cancer become high priorities, a growing use of next generation sequencing to identify new targets, and new data and greater acceptance… Read More
#LCSM 
You must be logged in to post a comment.